Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 1 Jul 2017

Zhang Dakai, Zhang Wei, Liu Wenzhi, Mao Yu, Fu Zhanzhao, Liu Jia, Huang Wei, Zhang Zicheng, An Dianzheng, Li Baosheng

Abstract excerpt

BACKGROUND AND PURPOSE: A retrospective study was carried out to analyze multiple prognostic predictors, including human papillomavirus (HPV) infection for chemoradiation treatment of esophageal squamous cell carcinoma (ESCC). MATERIALS AND METHODS: DNA extracted from a total of 192 patients treated with chemoradiation for locally advanced ESCC was examined to determine HPV status by polymerase chain reaction...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Chemoradiotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Viral

Share to Esophageal Neoplasms

Share to Esophageal Squamous Cell Carcinoma

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 28647401
DOI: 10.1016/j.radonc.2017.06.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.PMID 28647401Read ↗

Human papillomavirus infection and p53 mutation in esophageal squamous cell carcinoma and its impact on treatment outcome.Semantic proximity Read ↗

Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.Semantic proximity Read ↗

HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.Semantic proximity Read ↗

Prognostic value of human papillomavirus in anal squamous cell carcinoma.Semantic proximity Read ↗

The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability.Semantic proximity Read ↗

Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.Semantic proximity Read ↗

Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy.Semantic proximity Read ↗

The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous-cell carcinoma: a meta-analysis.Semantic proximity Read ↗

Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma.Semantic proximity Read ↗

p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.Semantic proximity Read ↗

Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.Semantic proximity Read ↗

Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.